Market Flux Event
Galderma Agrees to Buy ZO Skin Health for $1.5 Billion in All-Cash Deal
Read this in the Market Flux appSwiss dermatology company Galderma Group agreed to acquire ZO Skin Health from its shareholders for an enterprise value of $1.5 billion in an all-cash transaction. The sellers include the Obagi family and funds managed by Blackstone Tactical Opportunities.
The purchase expands Galderma's physician-dispensed skincare portfolio in the United States, strengthening its foothold in a market where ZO Skin Health, founded by dermatologist Zein Obagi, has built a significant presence through doctor's offices and medical spas.
© AI-generated summary is provided by Market Flux
Sources
- NasdaqGalderma To Acquire ZO Skin Health For $1.5 Bln
- WsjGalderma to Buy ZO Skin Health for $1.5 Billion
- BusinessGalderma Group agreed to buy Zo Skin Health for an enterprise value of $1.5 billion in an all-cash transaction that expands the Swiss dermatology company’s physician-dispensed skincare portfolio in the US.